Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Mubadala Investment Company

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 127
Average round size
info
The average size of a deal this fund participated in
$382M
Portfolio companies 73
Rounds per year 18.14
Lead investments 4
Exits 7
Key employees 2
Stages of investment
Early Stage Venture
Late Stage Venture

Areas of investment

  • Biotechnology
  • Health Care
  • Software
  • Therapeutics
  • Life Science
Summary

Mubadala Investment Company appeared to be the VC, which was created in 2002. The main office of represented VC is situated in the Abu Dhabi. The company was established in Asia in United Arab Emirates.

The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Mubadala Investment Company, startups are often financed by Redpoint, New Enterprise Associates, Founders Fund. The meaningful sponsors for the fund in investment in the same round are Union Square Ventures, Temasek Holdings, Sun Life Financial. In the next rounds fund is usually obtained by SoftBank Investment Advisers, Union Square Ventures, Temasek Holdings.

For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Didi Chuxing, C2FO, Primer. The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most successful fund investment fields, there are Biotechnology, Finance.

The overall number of key employees were 4.

The fund is generally included in less than 2 deals every year. The top activity for fund was in 2018. The typical startup value when the investment from Mubadala Investment Company is more than 1 billion dollars. Considering the real fund results, this VC is 12 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of more than 100 millions dollars. This Mubadala Investment Company works on 18 percentage points less the average amount of lead investments comparing to the other organizations.

Read more

Look at other 50 related and similar funds Collapse list
Fund NameLocation
350 Capital Canada, Ontario, Toronto
Ausum Ventures California, San Francisco, United States
Ceres Partners Indiana, South Bend, United States
CityRock Venture Partners New York, New York, United States
CRS Recycling Services -
FLIR Systems Oregon, United States, Wilsonville
Foundation Medicine Cambridge, Massachusetts, United States
FreeBit Co, Ltd Chiyoda, Japan
Innovation Birmingham Campus Birmingham, England, United Kingdom
Kardan Amsterdam, Noord-Holland, The Netherlands
Mingxin China Growth Fund Beijing, Beijing, China
Motianshi Touzi China, Guangdong, Guangzhou
Pomegranate Investment AB -
Sphera Funds Management Israel, Tel Aviv, Tel Aviv District
SymphonyAlpha Ventures Madison, United States, Wisconsin
Validus Growth Investors California, San Diego, United States
VitaTech S.A -
Yizheng Tiandao Beijing, Beijing, China
Zhejiang Daily Digital Culture China, Hangzhou, Zhejiang

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Flip Fit

E-Commerce
Fashion
Shopping
Social Media
$144M02 Apr 2024 Los Angeles, California, United States

Capstan Therapeutics

Biotechnology
Health Care
Therapeutics
$175M20 Mar 2024 San Diego, California, United States

Rejuveron Life Sciences

Biotechnology
Health Care
Medical
$75M13 Sep 2023 Zurich, Switzerland

Georgiamune

Biotechnology
Health Care
Therapeutics
$75M09 Aug 2023 Gaithersburg, Maryland, United States

EpiBiologics

Biotechnology
Health Care
Medical
Therapeutics
$23M20 Jul 2023 San Mateo, California, United States

Matera

Accounting
Construction
Real Estate
$8M03 Jul 2023 Paris, Ile-de-France, France

TreasurySpring

Banking
Consulting
Financial Services
FinTech
Venture Capital
$29M21 Jun 2023 London, England, United Kingdom

Outpace Bio

Biotechnology
Health Care
Life Science
Pharmaceutical
$25M23 Mar 2023 Seattle, Washington, United States

EpiBiologics

Biotechnology
Health Care
Medical
Therapeutics
$50M22 Mar 2023 San Mateo, California, United States
News
Open Mineral Raises $33M in Series C Funding

– Open Mineral develops a blockchain-based platform for the supply chain of raw materials.
– Series C round $33m brings company valuation to $120m.
– The round was led by Mubadala Investment Company with participation from existing investors Xploration Capital and Emerald Technology Ventures and new investors Statkraft and Lingfeng Capital.
– The new investment will be aimed at accelerating its growth, solidifying its physical supply chain merchant activities, and advancing its position in digitizing metal raw material trading.

Dubai-based buy now, pay later platform tabby raises $50M at $300M valuation

– Tabby, a buy now, pay later solution, raised $50m in Series B funding.
– The round was led by Global Founders Capital and STV, with participation from Delivery Hero and CCVA.
– Existing investors, including Arbor Ventures, Mubadala Investment Capital and others also participated.
– The company plans to use the funding to expand its operations in the region.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Mubadala Investment Company?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 127
Average round size 382M
Rounds per year 18.14
Peak activity year 2020
Lead investments 4
Exits 7
Group Appearance index 0.18

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Flip Fit

E-Commerce
Fashion
Shopping
Social Media
$144M02 Apr 2024 Los Angeles, California, United States

Capstan Therapeutics

Biotechnology
Health Care
Therapeutics
$175M20 Mar 2024 San Diego, California, United States

Rejuveron Life Sciences

Biotechnology
Health Care
Medical
$75M13 Sep 2023 Zurich, Switzerland

Georgiamune

Biotechnology
Health Care
Therapeutics
$75M09 Aug 2023 Gaithersburg, Maryland, United States

EpiBiologics

Biotechnology
Health Care
Medical
Therapeutics
$23M20 Jul 2023 San Mateo, California, United States

Matera

Accounting
Construction
Real Estate
$8M03 Jul 2023 Paris, Ile-de-France, France

TreasurySpring

Banking
Consulting
Financial Services
FinTech
Venture Capital
$29M21 Jun 2023 London, England, United Kingdom

Outpace Bio

Biotechnology
Health Care
Life Science
Pharmaceutical
$25M23 Mar 2023 Seattle, Washington, United States

EpiBiologics

Biotechnology
Health Care
Medical
Therapeutics
$50M22 Mar 2023 San Mateo, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: